Feature

AML Complexity Uncovered: A Unified Whole Genome and Informatics Approach for High Resolution Disease Understanding

Standard-of-care (SOC) genomic testing in acute myeloid leukemia (AML) has historically resulted in fragmented, incomplete genomic profiles that mask clinically significant biology.

  • March 12, 2026

Share

The recent webinar highlights the shift in hematological research towards a unified whole genome sequencing (WGS) approach, offering deeper insights into the complex genomics of Acute Myeloid Leukemia (AML). It discusses the significance of findings from the MEASURE–ATLAS study, including pathogenic variants often overlooked by standard of care testing. Participants learned how WGS can reveal inherited predispositions and structural variants with important prognostic implications. The session also covered the necessary technical and computational capabilities for implementing a WGS-based research workflow in hematology.

Original Source(s)

AML Complexity Uncovered: A Unified Whole Genome and Informatics Approach for High Resolution Disease Understanding

  • March 12, 2026

Related Content

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program

GIMEMA ALL2820: Chemotherapy-Free Regimen Studied in Front-Line Setting

As front-line therapy, a chemotherapy-free regimen combining the tyrosine kinase inhibitor (TKI) ponatinib and the bispecific T-cell engager blinatumomab significantly outperformed standard treatment ...

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance